RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32861747http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32861747http://www.w3.org/2000/01/rdf-schema#comment"mTOR inhibitors are considered today to be one of the most promising anticancer drugs. Here to study the mechanism of the acquired resistance of MCF-7 breast cancer cells to mTOR inhibitors two different models of the cell resistance were used: rapamycin-resistant MCF-7/Rap subline developed under long-term rapamycin treatment, and metformin-resistant MCF-7/M subline obtained by long-term metformin treatment. We have found that both resistant sublines were characterized by common features: increased expression of mTOR-interacting Raptor protein, increased phosphorylation of Akt, and activation of growth-related transcriptional factor AP-1. Cell response to mTOR inhibitors was partially restored under treatment with PI3K inhibitor wortmannin supporting the direct connection between Akt activation and poor cell response to therapeutic drugs. Transfection of mir-181c, one of the positive regulators of Akt and mTOR, led to an increase in the cell resistance to both mTOR inhibitors, rapamycin and metformin, which correlated with Raptor overexpression and activation of Akt/AP-1 signaling. In general, the effect of Raptor overexpression in the resistant cells, as well as the ability of mir-181c to modulate the Raptor expression, can open novel perspectives in the treatment of rapalogues-resistant cancers, based on the drugs design targeting mir-181c/Raptor axis."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.org/dc/terms/identifier"doi:10.1016/j.cbi.2020.109243"xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Nemtsova M."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Sorokin D."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Scherbakov A."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Berstein L."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Andreeva O."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Bure I."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Gudkova M."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Krasil'nikov M."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Mikhaevich E."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Shchegolev Y."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/author"Shunaev A."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/name"Chem Biol Interact"xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/pages"109243"xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/title"Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells."xsd:string
http://purl.uniprot.org/citations/32861747http://purl.uniprot.org/core/volume"330"xsd:string
http://purl.uniprot.org/citations/32861747http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/32861747
http://purl.uniprot.org/citations/32861747http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/32861747
http://purl.uniprot.org/uniprot/#_B7Z3S8-mappedCitation-32861747http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32861747
http://purl.uniprot.org/uniprot/#_B4DJ80-mappedCitation-32861747http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32861747
http://purl.uniprot.org/uniprot/#_Q6DKI0-mappedCitation-32861747http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32861747
http://purl.uniprot.org/uniprot/#_Q8N122-mappedCitation-32861747http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32861747